View Older Stories View More Recent Stories
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citizens Financial Group Announces Second Quarter 2026 Earnings Conference Call Details
-
Euronext publishes Q1 2026 results
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Vitable Health Launches AI-Powered ACA Autopilot, Making Enterprise-Grade ACA Compliance Accessible to Every Employer
-
SRS Acquiom Welcomes Sallie Krawcheck and Philip Vasan to Board of Directors
-
Norm Law Adds Veteran Corporate Transactions Partner James Gerkis
-
Bluevine Study Reveals 2 in 3 Small Business Owners Lose Sleep Over Financial Stress
-
StitcherAI Launches IT Investment ROI Platform to Answer the Question Every Board Is Asking: Are My AI Investments Paying Off?
-
The Trust for the Americas and the Organization of American States Present the 2025 Corporate Citizen of the Americas Award to Mastercard
-
Telephone & Data Systems (TDS) PT Lowered to $50 at Citi
-
CitiTrends Sets Date for First Quarter 2026 Earnings Release and Conference Call
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citizens Reiterates Market Outperform Rating on Snowflake (SNOW) Amid Slowing Guidance
-
Google set to showcase AI model updates, search overhaul at annual I/O conference
-
Stellantis to push US revival, brands and Chinese deals in high-stakes pitch to investors
-
Form 424B2 CITIGROUP INC
-
Trading Day: Yields squeeze stocks
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citi Starts BridgeBio Pharma (BBIO) at Neutral
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
CFRA Downgrades Citi (C) to Hold
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
iQIYI (IQ) PT Lowered to $1.80 at Citi
-
Form 424B2 CITIGROUP INC
-
Citizens Financial Group to Participate at the Morgan Stanley U.S. Financials Conference

